Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring
Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising
Couples HIV testing and counselling prompts rapid switch to consistent condom use in South African study
Swiss research identifies factors associated with use of non-recommended HIV therapy
'Real-world' evidence shows that antiretroviral therapy reduces risk of HIV transmission in heterosexual couples
FDA Advisory Committee recommends accelerated approval of bedaquiline for drug-resistant TB
Out-of-clinic adherence club for delivery of ARVs shows better retention than standard of care
Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon
